CR9838A - Derivados de sulfonamida para el tratamiento de enfermedades - Google Patents

Derivados de sulfonamida para el tratamiento de enfermedades

Info

Publication number
CR9838A
CR9838A CR9838A CR9838A CR9838A CR 9838 A CR9838 A CR 9838A CR 9838 A CR9838 A CR 9838A CR 9838 A CR9838 A CR 9838A CR 9838 A CR9838 A CR 9838A
Authority
CR
Costa Rica
Prior art keywords
diseases
treatment
sulfonamide derivatives
preparation
derivatives
Prior art date
Application number
CR9838A
Other languages
English (en)
Inventor
Edgard Bunnage Mark
Alan Glossop Paul
Daniel Brown Alan
James Kim
Alice Louise Lane Charlotte
Andrew Lewthwaite Russel
Brian Moses Ian
Anthony Price David
Murria Thomson Nicholas
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34890770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9838(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0406387A external-priority patent/GB0406387D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of CR9838A publication Critical patent/CR9838A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

La invencion se refiere a compuestos de formula 1 y a procedimientos para la preparacion de, a intermedios usados en la preparacion de, a composiciones que contienen y a los usos de tales derivados. Los compuestos de acuerdo con la presente invencion son utiles en numerosas enfermedades, trastornos y afecciones inflamatorias, alergicas y respiratorias.
CR9838A 2004-01-22 2008-03-27 Derivados de sulfonamida para el tratamiento de enfermedades CR9838A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290169 2004-01-22
GB0406387A GB0406387D0 (en) 2004-03-22 2004-03-22 Sulfonamide derivatives for the treatment of diseases
US60026004P 2004-08-09 2004-08-09

Publications (1)

Publication Number Publication Date
CR9838A true CR9838A (es) 2008-04-21

Family

ID=34890770

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9838A CR9838A (es) 2004-01-22 2008-03-27 Derivados de sulfonamida para el tratamiento de enfermedades

Country Status (7)

Country Link
CR (1) CR9838A (es)
CY (1) CY1107107T1 (es)
EC (1) ECSP066700A (es)
HK (1) HK1096379A1 (es)
HR (1) HRP20070542T3 (es)
IL (1) IL176564A (es)
MA (1) MA28302A1 (es)

Also Published As

Publication number Publication date
IL176564A0 (en) 2006-10-31
CY1107107T1 (el) 2012-10-24
ECSP066700A (es) 2006-10-31
HK1096379A1 (en) 2007-06-01
HRP20070542T3 (en) 2008-02-29
MA28302A1 (fr) 2006-11-01
IL176564A (en) 2011-11-30

Similar Documents

Publication Publication Date Title
UY28724A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
UY28721A1 (es) Derivados de sulfonamida para eltratamiento de enfermedades
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
ECSP056164A (es) Compuestos utiles para el tratamiento de enfermedades
CR10700A (es) Derivados de sulfonamida
GT200400116A (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades.
UY28343A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
UY30224A1 (es) Derivados de amina
CR8636A (es) Compuestos utiles para el tratamiento de enfermedades
ECSP066975A (es) Derivados de fenol y tiofenol 3-o 4-monosustituidos utiles como ligandos de h3
CR9838A (es) Derivados de sulfonamida para el tratamiento de enfermedades
UY28819A1 (es) Derivados de formamida para el tratamiento de enfermedades
CR8513A (es) Derivados de sulfonamida para el tratamiento de enfermedades
DOP2004000921A (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
CR8514A (es) Derivados de sulfonamida para el tratamiento de enfermedades
ECSP066854A (es) Compuestos utiles para el tratamiento de enfermedades
DOP2004000902A (es) Compuestos utiles para el tratamiento de enfermedades
UY28816A1 (es) Compuestos para el tratamiento de enfermedades
DOP2005000037A (es) Compuestos utiles para el tratamiento de enfermedades
DOP2005000043A (es) Compuestos para el tratamiento de enfermedades
CU23537B7 (es) Derivados de sulfonamida para el tratamiento de enfermedades
CU23532B7 (es) Derivados de sulfonamida para el tratamiento de enfermedades
GT200500056A (es) Compuestos utiles para el tratamiento de enfermedades
DOP2005000041A (es) Compuestos para el tratamientos de enfermandades

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)